159 related articles for article (PubMed ID: 32759798)
1. Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro.
Justin S; Rutz J; Maxeiner S; Chun FK; Juengel E; Blaheta RA
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759798
[TBL] [Abstract][Full Text] [Related]
2. Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells.
Justin S; Rutz J; Maxeiner S; Chun FK; Juengel E; Blaheta RA
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32512849
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane inhibits proliferation and invasive activity of everolimus-resistant kidney cancer cells in vitro.
Juengel E; Maxeiner S; Rutz J; Justin S; Roos F; Khoder W; Tsaur I; Nelson K; Bechstein WO; Haferkamp A; Blaheta RA
Oncotarget; 2016 Dec; 7(51):85208-85219. PubMed ID: 27863441
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro.
Xie H; Rutz J; Maxeiner S; Grein T; Thomas A; Juengel E; Chun FK; Cinatl J; Haferkamp A; Tsaur I; Blaheta RA
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474751
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane as an adjunctive to everolimus counteracts everolimus resistance in renal cancer cell lines.
Juengel E; Euler S; Maxeiner S; Rutz J; Justin S; Roos F; Khoder W; Nelson K; Bechstein WO; Blaheta RA
Phytomedicine; 2017 Apr; 27():1-7. PubMed ID: 28314474
[TBL] [Abstract][Full Text] [Related]
6. Curcumin combined with exposure to visible light blocks bladder cancer cell adhesion and migration by an integrin dependent mechanism.
Mani J; Fleger J; Rutz J; Maxeiner S; Bernd A; Kippenberger S; Zöller N; Chun FK; Relja B; Juengel E; Blaheta RA
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10564-10574. PubMed ID: 31841214
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane Reduces Prostate Cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7.
Rutz J; Thaler S; Maxeiner S; Chun FK; Blaheta RA
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218199
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT‑1.
Wang F; Liu P; An H; Zhang Y
Int J Mol Med; 2020 Sep; 46(3):1085-1095. PubMed ID: 32705150
[TBL] [Abstract][Full Text] [Related]
9. mTOR inhibition reduces growth and adhesion of hepatocellular carcinoma cells in vitro.
Engl T; Rutz J; Maxeiner S; Juengel E; Roos F; Khoder W; Bechstein WO; Nelson K; Tsaur I; Haferkamp A; Blaheta RA
Mol Med Rep; 2017 Nov; 16(5):7064-7071. PubMed ID: 28901501
[TBL] [Abstract][Full Text] [Related]
10. Amygdalin influences bladder cancer cell adhesion and invasion in vitro.
Makarević J; Rutz J; Juengel E; Kaulfuss S; Tsaur I; Nelson K; Pfitzenmaier J; Haferkamp A; Blaheta RA
PLoS One; 2014; 9(10):e110244. PubMed ID: 25333694
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).
Islam SS; Mokhtari RB; Akbari P; Hatina J; Yeger H; Farhat WA
Target Oncol; 2016 Apr; 11(2):209-27. PubMed ID: 26453055
[TBL] [Abstract][Full Text] [Related]
12. The Inhibitory Effect of Sulforaphane on Bladder Cancer Cell Depends on GSH Depletion-Induced by Nrf2 Translocation.
He C; Buongiorno LP; Wang W; Tang JCY; Miceli N; Taviano MF; Shan Y; Bao Y
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443505
[TBL] [Abstract][Full Text] [Related]
13. TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells.
Jin CY; Molagoda IMN; Karunarathne WAHM; Kang SH; Park C; Kim GY; Choi YH
Toxicol Appl Pharmacol; 2018 Aug; 352():132-141. PubMed ID: 29792947
[TBL] [Abstract][Full Text] [Related]
14. HDAC inhibition suppresses bladder cancer cell adhesion to collagen under flow conditions.
Juengel E; Meyer dos Santos S; Schneider T; Makarevic J; Hudak L; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
Exp Biol Med (Maywood); 2013 Nov; 238(11):1297-304. PubMed ID: 24006305
[TBL] [Abstract][Full Text] [Related]
15. Chronic Sulforaphane Application Does Not Induce Resistance in Renal Cell Carcinoma Cells.
Rutz J; Juengel E; Euler S; Maxeiner S; Justin S; Roos F; Chun FK; Blaheta RA
Anticancer Res; 2018 Nov; 38(11):6201-6207. PubMed ID: 30396938
[TBL] [Abstract][Full Text] [Related]
16. Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.
van der Horst G; Bos L; van der Mark M; Cheung H; Heckmann B; Clément-Lacroix P; Lorenzon G; Pelger RC; Bevers RF; van der Pluijm G
PLoS One; 2014; 9(9):e108464. PubMed ID: 25247809
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
Lan F; Pan Q; Yu H; Yue X
J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
[TBL] [Abstract][Full Text] [Related]
18. The effect of sulforaphane on the cell cycle, apoptosis and expression of cyclin D1 and p21 in the A549 non-small cell lung cancer cell line.
Żuryń A; Litwiniec A; Safiejko-Mroczka B; Klimaszewska-Wiśniewska A; Gagat M; Krajewski A; Gackowska L; Grzanka D
Int J Oncol; 2016 Jun; 48(6):2521-33. PubMed ID: 27035641
[TBL] [Abstract][Full Text] [Related]
19. AKT1/HK2 Axis-mediated Glucose Metabolism: A Novel Therapeutic Target of Sulforaphane in Bladder Cancer.
Huang L; He C; Zheng S; Wu C; Ren M; Shan Y
Mol Nutr Food Res; 2022 Feb; 66(3):e2100738. PubMed ID: 34791822
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway.
Wang L; Tian Z; Yang Q; Li H; Guan H; Shi B; Hou P; Ji M
Oncotarget; 2015 Sep; 6(28):25917-31. PubMed ID: 26312762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
